219 related articles for article (PubMed ID: 35234938)
1. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution.
Song Y; He X; Yang W; Wu Y; Cui J; Tang T; Zhang R
Nucleic Acids Res; 2022 Mar; 50(5):2509-2521. PubMed ID: 35234938
[TBL] [Abstract][Full Text] [Related]
2. Detection of A-to-I RNA Editing in SARS-COV-2.
Picardi E; Mansi L; Pesole G
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052382
[TBL] [Abstract][Full Text] [Related]
3. Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2.
Ringlander J; Fingal J; Kann H; Prakash K; Rydell G; Andersson M; Martner A; Lindh M; Horal P; Hellstrand K; Kann M
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35064076
[TBL] [Abstract][Full Text] [Related]
4. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.
Vlachogiannis NI; Verrou KM; Stellos K; Sfikakis PP; Paraskevis D
Clin Immunol; 2021 May; 226():108699. PubMed ID: 33639276
[TBL] [Abstract][Full Text] [Related]
5. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
6. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
7. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
Kouwaki T; Nishimura T; Wang G; Oshiumi H
Front Immunol; 2021; 12():700926. PubMed ID: 34249006
[TBL] [Abstract][Full Text] [Related]
8. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
[TBL] [Abstract][Full Text] [Related]
9. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
[TBL] [Abstract][Full Text] [Related]
10. Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential.
Kubik S; Arrigo N; Bonet J; Xu Z
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834921
[TBL] [Abstract][Full Text] [Related]
11. The emerging plasticity of SARS-CoV-2.
McCormick KD; Jacobs JL; Mellors JW
Science; 2021 Mar; 371(6536):1306-1308. PubMed ID: 33766871
[No Abstract] [Full Text] [Related]
12. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
13. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
14. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
Prelli Bozzo C; Nchioua R; Volcic M; Koepke L; Krüger J; Schütz D; Heller S; Stürzel CM; Kmiec D; Conzelmann C; Müller J; Zech F; Braun E; Groß R; Wettstein L; Weil T; Weiß J; Diofano F; Rodríguez Alfonso AA; Wiese S; Sauter D; Münch J; Goffinet C; Catanese A; Schön M; Boeckers TM; Stenger S; Sato K; Just S; Kleger A; Sparrer KMJ; Kirchhoff F
Nat Commun; 2021 Jul; 12(1):4584. PubMed ID: 34321474
[TBL] [Abstract][Full Text] [Related]
15. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.
Heraud-Farlow JE; Chalk AM; Linder SE; Li Q; Taylor S; White JM; Pang L; Liddicoat BJ; Gupte A; Li JB; Walkley CR
Genome Biol; 2017 Sep; 18(1):166. PubMed ID: 28874170
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
Andreano E; Piccini G; Licastro D; Casalino L; Johnson NV; Paciello I; Dal Monego S; Pantano E; Manganaro N; Manenti A; Manna R; Casa E; Hyseni I; Benincasa L; Montomoli E; Amaro RE; McLellan JS; Rappuoli R
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34417349
[TBL] [Abstract][Full Text] [Related]
17. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
[TBL] [Abstract][Full Text] [Related]
18. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
19. ADAR1: A New Target for Immuno-oncology Therapy.
Bhate A; Sun T; Li JB
Mol Cell; 2019 Mar; 73(5):866-868. PubMed ID: 30849393
[TBL] [Abstract][Full Text] [Related]
20. Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route.
Pan T; Chen R; He X; Yuan Y; Deng X; Li R; Yan H; Yan S; Liu J; Zhang Y; Zhang X; Yu F; Zhou M; Ke C; Ma X; Zhang H
Signal Transduct Target Ther; 2021 Dec; 6(1):420. PubMed ID: 34907154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
